Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:DCI
NYSE:DCIMachinery

Assessing Donaldson Company (DCI) Valuation After The Recent Share Price Pullback

Why Donaldson Company (DCI) is on investors’ radar today Recent performance in Donaldson Company (DCI) shares, including a roughly 20% decline over the past month and an 8% decline over the past 3 months, has drawn fresh investor attention. With the stock last closing at US$83.87 and a market value of about US$9.8b, investors are weighing how the filtration specialist’s current valuation compares with its business mix and profitability. See our latest analysis for Donaldson Company. The...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Alphabet (GOOGL) Faces Design-Liability Verdict on YouTube Algorithms – What Does It Mean for AI Ambitions?

Earlier this week, a Los Angeles jury ruled that Alphabet’s Google and Meta designed YouTube and Instagram in ways that contributed to a young woman’s social media addiction and mental health harms, awarding a combined US$6.00 million in compensatory and punitive damages and finding both companies failed to adequately warn users about these risks. This verdict targets the core design of engagement-driving features rather than user content, potentially reshaping legal protections under...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Does WalkAI’s Medtech Accolades Recast Zimmer Biomet’s (ZBH) Edge in Orthopedic and Digital Health?

Earlier in 2026, Zimmer Biomet was honored with three Healthcare Asia Medtech Awards for its iodine-treated hip implants, WalkAI recovery platform, and surgeon engagement initiatives, underscoring its focus on orthopedic and digital health innovation. The recognition for WalkAI, which applies artificial intelligence to monitor knee replacement recovery and enable earlier clinical intervention, highlights how Zimmer Biomet is pairing traditional implants with data-driven tools to support...
NYSE:ABBV
NYSE:ABBVBiotechs

AbbVie Dermatology Data Highlights Immunology Depth And Emerging Skin Disease Opportunities

AbbVie (NYSE:ABBV) is presenting new clinical research across its dermatology portfolio at the 2026 American Academy of Dermatology Annual Meeting. The company is showcasing data on treatment outcomes for immune mediated skin diseases, including late breaking Phase 3 results in vitiligo and alopecia areata. The presentations feature durable long term outcomes, quality of life measures, and investigational results for new indications. For investors, this update highlights how AbbVie is...
NYSE:UTI
NYSE:UTIConsumer Services

Does UTI’s Routine Insider Sale Underscore Confidence In Its Industry Partnerships And Training Expansion Strategy?

On March 17, 2026, Universal Technical Institute Director George W. Brochick disclosed an indirect sale of 5,000 shares in an SEC Form 4 filing, while the company continued to benefit from solid operating performance and a new multi-year equipment agreement with Fuji Spray Auto for student training. An interesting angle is that Brochick’s sale appears routine given his remaining holdings, keeping investor attention on Universal Technical Institute’s operational progress and its expanded...
SWX:SDZ
SWX:SDZPharmaceuticals

Assessing Sandoz Group (SWX:SDZ) Valuation After Strong One Year Shareholder Returns

Recent share performance snapshot Sandoz Group (SWX:SDZ) has seen a mix of short term pressure and longer term strength, with a 0.3% decline over the past day, 0.5% over the past week and 16.5% over the past month, but a 3.2% gain over the past 3 months and a 62.6% total return over the past year. See our latest analysis for Sandoz Group. The recent 30 day share price return of 16.5% contrasts with a 62.6% total shareholder return over the past year. This suggests that earlier gains have...
NasdaqGS:LIN
NasdaqGS:LINChemicals

How Investors Are Reacting To Linde (LIN) Margin Resilience And Operational Efficiency Outpacing Peers

In the past year, Linde has continued to outperform the specialty chemicals industry, driven by consistent profit growth, disciplined capital allocation, and high operational efficiency across its global industrial gases portfolio. A key insight is that Linde’s robust, contract-backed project pipeline, combined with cost controls and automation, appears to be reinforcing its margins and operational resilience, even as peers face a more mixed backdrop. We’ll now examine how Linde’s ongoing...
TSXV:ELE
TSXV:ELEMetals and Mining

What Elemental Royalty (TSXV:ELE)'s First Profit and Dividend Launch Means For Shareholders

Elemental Royalty Corporation has reported its 2025 full-year results, with sales rising to US$43.64 million and net income reaching US$1.77 million, and has also introduced a maiden quarterly dividend of US$0.03 per share starting March 2026. Following its merger with EMX Royalty Corporation, Elemental Royalty now controls a substantially expanded portfolio of royalties and streams, while also innovating with an option for shareholders to receive the inaugural dividend in XAUT digital gold...
NYSE:MKC
NYSE:MKCFood

Is McCormick’s (MKC) Black Currant Push a Sign of Deeper Brand Strategy Shifts?

Earlier this week, McCormick expanded its 2026 Flavor of the Year campaign by rolling out Black Currant seasoning and finishing sugar, and by hosting Sensoria: The Black Currant Experience in New York, a multisensory event that brought the flavor trend to consumers and culinary professionals. This push around Black Currant underlines how McCormick uses trend-driven product innovation and immersive brand experiences to deepen engagement with both home cooks and foodservice partners. Next,...
NYSE:LMT
NYSE:LMTAerospace & Defense

Has Lockheed Martin (LMT) Already Priced In Defense Budget Tailwinds After Strong Share Gains?

For readers wondering whether Lockheed Martin at around US$615 per share still offers value, or if most of the easy gains are behind it, this article walks through what the current price may be implying. The stock has given investors a 23.9% return year to date and 43.3% over the last year, with a 90.0% return across five years. However, the past 7 days and 30 days show declines of 1.8% and 4.9% respectively. Recent headlines have focused on Lockheed Martin's role in global defense programs...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

The Bull Case For Merit Medical Systems (MMSI) Could Change Following Medtronic ViaVerte Distribution Deal - Learn Why

On 24 March 2026, Medtronic announced a distribution agreement with Merit Medical Systems to offer ViaVerte, an FDA-cleared, minimally invasive basivertebral nerve ablation system for chronic vertebrogenic lower back pain, extending an existing supply relationship between the two companies. This agreement gives Merit access to Medtronic’s broad pain management distribution network, potentially increasing physician adoption of ViaVerte and reinforcing Merit's position in outpatient spine...
NYSE:GEL
NYSE:GELOil and Gas

Does Sexual Assault Lawsuit And Governance Scrutiny Change The Bull Case For Genesis Energy (GEL)?

In March 2026, Genesis Energy and a current board member were sued in Harris County State Court for alleged repeated sexual assaults against a Jane Doe, with the complaint seeking US$50,000,000 in compensatory and punitive damages. The involvement of a sitting director and high-profile litigator Tony Buzbee, known for very large sexual assault outcomes, raises important questions about Genesis Energy’s governance and reputational risk controls. Against this backdrop, we’ll explore how the...
NYSE:CTRI
NYSE:CTRIConstruction

Did Adding Veteran Contractor Steven Nielsen to the Board Just Shift Centuri Holdings' (CTRI) Investment Narrative?

Centuri Holdings, Inc. recently expanded its Board of Directors by appointing specialty contracting veteran Steven E. Nielsen, former Chairman and CEO of Dycom Industries, effective March 20, 2026. Nielsen brings three decades of telecom and infrastructure contracting leadership, including scaling Dycom’s revenue from under US$200 million to more than US$4.50 billion, potentially enriching Centuri’s governance with deep execution and growth experience. Next, we’ll examine how adding an...
NYSE:HRL
NYSE:HRLFood

Hormel Foods (HRL) Valuation Check As AI Supply Chain Overhaul Targets 2026 Income Growth

Hormel Foods (HRL) is in the middle of a wide supply chain overhaul, highlighted by the o9 Digital Brain rollout, an AI-driven planning platform that targets tighter forecasting and more disciplined, demand-driven operations. See our latest analysis for Hormel Foods. Despite the recent rollout of its AI-powered planning platform and ongoing transformation program, Hormel Foods’ share price has declined 1.37% year-to-date and its 1-year total shareholder return has declined 20.58%, pointing to...
NYSE:PL
NYSE:PLProfessional Services

Planet Labs (PL) Is Down 8.8% After Berlin Expansion And ESOP Shelf Filing - Has The Bull Case Changed?

Planet Labs PBC recently reported fourth-quarter and full-year results showing higher sales alongside wider losses, issued revenue guidance for the first quarter of fiscal 2027 and the full year, and filed a US$680.66 million shelf registration for an ESOP-related offering of 20,119,874 Class A shares. The company is also expanding its Berlin satellite manufacturing facility to double Pelican fleet production, supporting a growing backlog and government contracts while moving to redeem...
NYSE:JOBY
NYSE:JOBYAirlines

Assessing Joby Aviation’s (NYSE:JOBY) Valuation After Recent Share Price Weakness

Joby Aviation (JOBY) has drawn investor attention recently as the stock logged a 4.4% one day decline, extending losses over the past week, month, and past 3 months despite a positive one year total return. See our latest analysis for Joby Aviation. The recent 4.4% one day share price decline to US$8.10 extends a weak short term pattern. However, the 1 year total shareholder return of 32.6% suggests earlier optimism has not fully reversed, which points to fading momentum rather than a new...